Author/Authors :
Scotti، نويسنده , , Vieri and Desideri، نويسنده , , Isacco and Meattini، نويسنده , , Icro and Cataldo، نويسنده , , Vanessa Di and Cecchini، نويسنده , , Sara and Petrucci، نويسنده , , Alessia and Franzese، نويسنده , , Ciro and Greto، نويسنده , , Daniela and Livi، نويسنده , , Lorenzo and Bonomo، نويسنده , , Pierluigi and Biti، نويسنده , , Giampaolo، نويسنده ,
Abstract :
Summary
matory breast cancer represents a rare and extremely aggressive subtype of breast cancer. Due to its rarity, prospective studies are a difficult goal to obtain in this field.
ys a multimodal approach seems to be the standard approach. Role and timing of surgery, radiotherapy and chemotherapy are still debated issues. In this scenario interest is rising in molecular and target therapies.
formed a review analyzing the management of this unfavorable disease focusing on the role of radiotherapy, with particular emphasis on levels of evidence.
Keywords :
Inflammatory breast cancer , Level of evidence , advanced breast cancer , Multimodality treatment , bolus